Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Maravai LifeSciences Holdings, Inc. - Class A common stock
(NQ:
MRVI
)
6.585
+0.015 (+0.23%)
Streaming Delayed Price
Updated: 10:05 AM EDT, Aug 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Maravai LifeSciences Holdings, Inc. - Class A common stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
July 22, 2026
From
Maravai LifeSciences, Inc.
Via
Business Wire
TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology
July 20, 2026
From
TriLink BioTechnologies, LLC
Via
Business Wire
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
June 16, 2026
From
Maravai LifeSciences
Via
Business Wire
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032
June 03, 2026
From
Maravai LifeSciences Holdings, Inc.
Via
Business Wire
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
May 18, 2026
From
Maravai LifeSciences, Inc.
Via
Business Wire
Maravai LifeSciences Reports First Quarter 2026 Financial Results
May 07, 2026
From
Maravai LifeSciences Holdings, Inc.
Via
Business Wire
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
April 20, 2026
From
Maravai LifeSciences, Inc.
Via
Business Wire
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results
February 25, 2026
From
Maravai LifeSciences Holdings, Inc.
Via
Business Wire
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
February 09, 2026
From
Maravai LifeSciences, Inc.
Via
Business Wire
Maravai LifeSciences Announces November 2025 Investor Conference Schedule
November 10, 2025
From
Maravai LifeSciences, Inc.
Via
Business Wire
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
November 06, 2025
From
Maravai LifeSciences Holdings, Inc.
Via
Business Wire
MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders
October 29, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
October 22, 2025
From
Maravai LifeSciences, Inc.
Via
Business Wire
MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
October 02, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 09, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
August 11, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
July 28, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
July 25, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 22, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 14, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
July 08, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
June 27, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
June 25, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Maravai ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
June 24, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
June 09, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
June 03, 2025
From
TriLink BioTechnologies
Via
Business Wire
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
May 21, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
Maravai LifeSciencesReleases 2024 Sustainability Report
May 21, 2025
From
Maravai LifeSciences Holdings LLC
Via
GlobeNewswire
TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions
May 20, 2025
From
TriLink BioTechnologies
Via
Business Wire
TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines
May 14, 2025
From
TriLink BioTechnologies
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
